Latest filing published 28 Sept 2026 for Calumet, Inc. /DE. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Stephen P. Mawer across 2 companies, led by Calumet, Inc. /DE and Calumet Specialty Products Partners, L.P. We count 17 filings; the first trade dates from 4 March 2022 and the latest from 25 September 2026.
Both buying and selling appear: 4 purchases worth €164k, against 4 sales worth €116k. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant and 8 option exercises. Since January 2026: no purchases and 1 sale on the market.
In size, the median ticket on the buying side is €38k. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 28 September 2026: an option exercise, in Calumet, Inc. /DE. The last purchase on record was published on 22 November 2022, which is 1,426 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations